Innova Biosciences introduces InnovaCoat GOLD-Carboxyl nanoparticles

25/07/2016

Innova Biosciences, a specialist provider of bioconjugation products and services, today announced the launch of a carboxylated derivative of its unique InnovaCoat® GOLD 40 nm nanoparticles. The new product enables customers to quickly generate highly stable covalent gold-antibody conjugates at R&D and manufacturing scales.

 

The InnovaCoat GOLD-Carboxyl surface is optimised for single step EDC (1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide) covalent coupling, without signs of aggregation, and eliminates the need for EDC/NHS (N-Hydroxysuccinimide) pre-activation and washing steps associated with traditional conjugations. The process is also significantly faster than standard methods, with conjugates ready to use in less than 35 minutes.
 
Anna Sereni, Team Leader of Particles at Innova Biosciences, commented: “The InnovaCoat GOLD-Carboxyl nanoparticles build upon Innova’s continuously expanding range of particle technologies, which also includes gold and latex conjugation kits, as well as pre-conjugated gold and colloidal gold. Innova’s broadening product range offers increased flexibility to those working within in-vitro diagnostics, as well as in other industries which utilize nanoparticle technologies.”
 
For more information, please visit: https://www.innovabiosciences.com/innovacoat-gold-nanoparticle-conjugation-kits/innovacoat-gold-carboxyl-40od-40nm.html
 
 
About Innova Biosciences Limited
Innova Biosciences are world leading experts in easy-to-use, cutting-edge bio conjugation technologies and services. The Company has the flexibility to support scientists from academia through to commercial manufacturing, developing and supplying reagent products to make science easier, both off-the shelf and to customer specification. Innova’s products are based on its antibody and protein labelling, nanoparticle, oligonucleotide labelling, and phosphate detection enzyme assay technologies.
 
All of Innova Biosciences’ product ranges are of the highest quality and are designed to streamline R&D and manufacturing processes, whilst also reducing overall project costs by cutting costs associated with e.g. material waste, in-house equipment, and staff time, providing increased return on investment compared to traditional methods.
 
Innova Biosciences’ ever expanding portfolio, including the Lightning-Link®, InnovaCoat® and Thunder-Link® brands, is available to research laboratories, pharmaceutical, biotechnology and diagnostic companies worldwide.
 
Innova Biosciences is a privately held company, and was founded in 2002.

*******
 
Media contact
Katie Odgaard, Zyme Communications
Email: katie.odgaard@zymecommunications.com
Phone: +44 (0)7787 502 947
_________________________________________

Babraham Bioscience Technologies Limited

Babraham Bioscience Technologies Ltd (BBT) is responsible for the commercial development of the Babraham Research Campus. The Babraham Research Campus is distinct in its co-location of bioscience companies with the Babraham Institute, a world-renowned research organisation. The Campus provides companies laboratory and office space together with access to outstanding scientific facilities in an ideal geographical location at the core of the Cambridge cluster.

Babraham Bioscience Technologies Limited directory information

Newsletter signup

Jobsletter signup